Organization (Academic)
Rosalind Franklin University of Medicine and Science
ClinicalTrials.gov lists Rosalind Franklin University of Medicine and Science as lead sponsor of 12 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Rosalind Franklin University of Medicine and Science: 12 lead-sponsored trials and 1 legal-entity registration.
Disease areas (14)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 3 |
| Acquired Immunodeficiency Syndrome | 1 |
| Cognitive Dysfunction | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
Showing 5 of 14 disease areas.
Trials by start year as sponsor or collaborator (13)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 1 |
| 2021 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2012 | 1 |
| 2010 | 1 |
Showing 10 of 13 years.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 40% hit target (n=5) | 20% on time (n=5) |
Journals published in (57)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Critical care medicine | 6 |
| Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association | 5 |
| Proceedings of the National Academy of Sciences of the United States of America | 3 |
| The Journal of biological chemistry | 3 |
| The Journal of trauma | 3 |
Showing 5 of 57 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 49 | 11 | 2025-04-29 |
Organization relationships (2)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| American Pain Society | Co sponsors trial with | 1 |
| Children's Hospital and Health System Foundation, Wisconsin | Co sponsors trial with | 1 |
Latest dated events (63)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2025-04-29 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-04-22 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-03-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-08-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-07-23 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 63 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CYCS | Trial collaborator | Biospecimen collected in a trial |
| CYCS | Trial collaborator | Mentioned in trial text |
Biomarkers this organization publishes on (96)
Shown in this order: most publications first.
Showing 5 of 96 biomarkers.
On Scientist.com
Rosalind Franklin University of Medicine and Science is linked to 8 research suppliers in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with Rosalind Franklin University of Medicine and Science Macromolecular X-Ray and Computing on Scientist.com
For prices, more details, or to contact Rosalind Franklin University of Medicine and Science Macromolecular X-Ray and Computing, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.